Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 156,079 229,843 273,203 611,547
Total Sell Value $13,472,349 $20,340,408 $24,241,430 $58,103,504
Total People Sold 5 5 6 7
Total Sell Transactions 13 19 25 55
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 1356
  Page 28 of 55  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Davis George Eric SVP, General Counsel   •       –      –    2011-07-22 4 AS $30.50 $115,900 D/D (3,800) 39,651     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-07-22 4 OE $11.74 $44,612 D/D 3,800 43,451     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2011-07-14 4 AS $30.00 $30,000 D/D (1,000) 131,093     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-07-14 4 AS $30.00 $551,340 D/D (18,378) 39,876     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-07-14 4 OE $17.54 $322,350 D/D 18,378 58,254     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-07-14 4 AS $30.00 $150,000 D/D (5,000) 36,455     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-07-14 4 OE $11.05 $55,250 D/D 5,000 41,455     -
   Wood Mark VP, Human Resources   •       –      –    2011-07-14 4 AS $30.00 $324,990 D/D (10,833) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2011-07-14 4 OE $21.51 $233,018 D/D 10,833 31,467     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-07-01 4 AS $27.50 $68,750 D/D (2,500) 39,876     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-07-01 4 OE $14.39 $35,975 D/D 2,500 42,376     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-07-01 4 AS $27.68 $69,200 D/D (2,500) 36,455     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-07-01 4 OE $11.05 $27,625 D/D 2,500 38,955     -
   Wood Mark VP, Human Resources   •       –      –    2011-06-23 4 AS $25.56 $9,481 D/D (371) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2011-06-22 4 AS $25.93 $42,647 D/D (1,645) 21,005     -
   Wood Mark VP, Human Resources   •       –      –    2011-06-22 4 OE $0.00 $25,797 D/D 2,645 22,650     -
   Baffi Robert EVP, Technical Operations   •       –      –    2011-06-07 4 OE $0.00 $0 D/D 2,000 83,160     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-06-07 4 OE $0.00 $0 D/D 1,500 39,651     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-06-07 4 OE $0.00 $0 D/D 2,000 39,876     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2011-06-07 4 OE $0.00 $0 D/D 2,500 46,478     -
   Wood Mark VP, Human Resources   •       –      –    2011-06-07 4 AS $27.46 $12,520 D/D (456) 20,005     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2011-06-07 4 OE $0.00 $0 D/D 5,000 132,093     -
   Wood Mark VP, Human Resources   •       –      –    2011-06-06 4 OE $0.00 $0 D/D 1,250 20,461     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2011-06-06 4 S $27.39 $54,772 D/D (2,000) 127,093     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-05-31 4 AS $28.50 $108,300 D/D (3,800) 38,151     -
  1356 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 28 of 55
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us